News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TaiGen Biotechnology Expects China Launch Of Novel Antibiotic In 2014



1/6/2014 11:23:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

January 6, 2014 -- TaiGen Biotechnology of Taiwan will launch its first product, a novel antibiotic, in China in the second half of 2014, according to the company’s Chairman and CEO, Ming-chu Hsu. Nemonoxacin is a treatment for pneumonia and skin infections. TaiGen sold China rights for nemonoxacin to Zhejiang Medicine Co. in 2012 for $8 million upfront. Approval of the antibiotic in Taiwan should follow in 2015, said the company. More details....

Stock Symbol: (SHA: 600216)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES